Related references
Note: Only part of the references are listed.TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability
Surbhi Chouhan et al.
AUTOPHAGY (2023)
Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance
Ruchi Ghildiyal et al.
CANCER RESEARCH (2022)
Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells
J. Joseph Melenhorst et al.
NATURE (2022)
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting
Mithila Sawant et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner
Suresh Bugide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
Sumit K. Subudhi et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib
Jiajia Gu et al.
LUNG CANCER (2020)
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
Kim N. Chi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation
Reyaz Ur Rasool et al.
CANCER DISCOVERY (2019)
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
Dorothee Liebschner et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)
Past, Current, and Future of Immunotherapies for Prostate Cancer
Adeline N. Boettcher et al.
FRONTIERS IN ONCOLOGY (2019)
Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
Nathan Karin et al.
CYTOKINE (2018)
Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT
Wan-Lin Lo et al.
NATURE IMMUNOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
TCR Signaling: Mechanisms of Initiation and Propagation
Adam H. Courtney et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Regulatory mechanisms in T cell receptor signalling
Guillaume Gaud et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer
Xinyan Wu et al.
ONCOTARGET (2017)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
Activated Cdc42-associated kinase 1 (ACK1) binds the sterile α motif (SAM) domain of the adaptor SLP-76 and phosphorylates proximal tyrosines
Youg R. Thaker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Effective combinatorial immunotherapy for castration-resistant prostate cancer
Xin Lu et al.
NATURE (2017)
New additions to the ClusPro server motivated by CAPRI
Sandor Vajda et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2017)
ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer
Kiran Mahajan et al.
CANCER CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
How the TRAMP Model Revolutionized the Study of Prostate Cancer Progression
Irwin H. Gelman
CANCER RESEARCH (2016)
Organoid culture systems for prostate epithelial and cancer tissue
Jarno Drost et al.
NATURE PROTOCOLS (2016)
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Kristen E. Pauken et al.
SCIENCE (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer (vol 161, pg 1215, 2015)
Dan Robinson et al.
CELL (2015)
Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach
Harshani R. Lawrence et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Scrutinizing calcium flux oscillations in T lymphocytes to deduce the strength of stimulus
Susan N. Christo et al.
SCIENTIFIC REPORTS (2015)
Small molecule inhibition of Csk alters affinity recognition by T cells
Boryana N. Manz et al.
ELIFE (2015)
ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers
K. Mahajan et al.
ONCOGENE (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
The calcium feedback loop and T cell activation: How cytoskeleton networks control intracellular calcium flux
Noah Joseph et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Androgen Receptor Activation in Castration-Recurrent Prostate Cancer: The Role of Src-Family and Ack1 Tyrosine Kinases
Irwin H. Gelman
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Insights into the initiation of TCR signaling
Arup K. Chakraborty et al.
NATURE IMMUNOLOGY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
Irfan A. Asangani et al.
MOLECULAR CELL (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
Julia E. Maxson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation
M. Buchwald et al.
ONCOGENE (2013)
Ack1: Activation and Regulation by Allostery
Ketan S. Gajiwala et al.
PLOS ONE (2013)
CSF3R Is Mutated in Chronic Neutrophilic Leukemia and Atypical CML
Cancer Discovery (2013)
Ack1 Tyrosine Kinase Activation Correlates with Pancreatic Cancer Progression
Kiran Mahajan et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes
Kiran Mahajan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Cancer-associated Mutations Activate the Nonreceptor Tyrosine Kinase Ack1
Victoria Prieto-Echaguee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma
Lynn T. Dengel et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation
Kiran Mahajan et al.
PLOS ONE (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Mohammad Azam et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
Marcella Fasso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
MHC class I and class II molecules are expressed in both human and mouse prostate tumor microenvironment
Navreet K. Nanda et al.
PROSTATE (2006)
Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli
Maria L. Galisteo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Phosphorylation of WASP by the Cdc42-associated kinase ACK1 - Dual hydroxyamino acid specificity in a tyrosine kinase
N Yokoyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: Role of Ack1 in polyubiquitination of tumor suppressor Wwox.
NP Mahajan et al.
CANCER RESEARCH (2005)
Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1
EH van der Horst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Biochemical properties of the Cdc42-associated tyrosine kinase ACK1 - Substrate specificity, autophosphorylation, and interaction with Hck
N Yokoyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells
K Yasuda et al.
JOURNAL OF IMMUNOLOGY (2002)
Structure of the carboxyl-terminal Src kinase, Csk
A Ogawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors
M Teo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases
M Kawabuchi et al.
NATURE (2000)
Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation
T Brdicka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
